Li N - Search Results

1

Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm.

Ge S, Xu CR, Li YM, Zhang YL, Li N, Wang FT, Ding L, Niu J. Ge S, et al. Among authors: li ym, li n. J Oncol. 2022 Sep 15;2022:2469592. doi: 10.1155/2022/2469592. eCollection 2022. J Oncol. 2022. PMID: 36157238 Free PMC article.

2

GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial.

Jia R, Mi Y, Yuan X, Kong D, Li W, Li R, Wang B, Zhu Y, Kong J, Ma Z, Li N, Mi Q, Gao S. Jia R, et al. Among authors: li w, li n, li r. J Oncol. 2020 Jan 30;2020:1607860. doi: 10.1155/2020/1607860. eCollection 2020. J Oncol. 2020. PMID: 32411232 Free PMC article.

3

Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.

Gao RQ, Sun JH, Ma YH, Xie YW, Shao GM, Wang C, Tan B, Liu K, Li K, Li N, Hu WY, Cao J. Gao RQ, et al. Among authors: li n, li k. J Oncol. 2023 Feb 23;2023:1875153. doi: 10.1155/2023/1875153. eCollection 2023. J Oncol. 2023. PMID: 36873738 Free PMC article.

4

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer.

Zhong M, Gong L, Li N, Guan H, Gong K, Zhong Y, Zhu E, Wang X, Jiang S, Li J, Lei Y, Liu Y, Chen J, Zheng Z. Zhong M, et al. Among authors: li j, li n. Front Oncol. 2023 Aug 29;13:1179897. doi: 10.3389/fonc.2023.1179897. eCollection 2023. Front Oncol. 2023. PMID: 37711200 Free PMC article.

5

The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer.

Yu W, Lin X, Leng S, Hou Y, Dang Z, Xue S, Li N, Zhang F. Yu W, et al. Among authors: li n. Transl Oncol. 2024 Aug;46:102014. doi: 10.1016/j.tranon.2024.102014. Epub 2024 Jun 5. Transl Oncol. 2024. PMID: 38843657 Free PMC article.

6

Wang X, Peng W, Zhao Y, Sha J, Li N, Huang S, Wang H. Wang X, et al. Among authors: li n. Front Oncol. 2024 Jun 6;14:1370801. doi: 10.3389/fonc.2024.1370801. eCollection 2024. Front Oncol. 2024. PMID: 38903709 Free PMC article.

7

Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer.

Dong W, Li N, Pei X, Wu X. Dong W, et al. Among authors: li n. Oncol Lett. 2018 Apr;15(4):4207-4214. doi: 10.3892/ol.2018.7881. Epub 2018 Jan 26. Oncol Lett. 2018. PMID: 29541187 Free PMC article.

8

TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis.

Hu W, Feng CM, Liu LY, Li N, Tian F, Du JX, Zhao Y, Xiang XX, Liu K, Zhao PQ. Hu W, et al. Among authors: li n. Front Oncol. 2019 May 22;9:400. doi: 10.3389/fonc.2019.00400. eCollection 2019. Front Oncol. 2019. PMID: 31179241 Free PMC article.

9

ILF2 promotes anchorage independence through direct regulation of PTEN.

Li N, Liu T, Li H, Zhang L, Chu L, Meng Q, Qiao Q, Han W, Zhang J, Guo M, Zhao J. Li N, et al. Among authors: li h. Oncol Lett. 2019 Aug;18(2):1689-1696. doi: 10.3892/ol.2019.10510. Epub 2019 Jun 21. Oncol Lett. 2019. PMID: 31423236 Free PMC article.

10

Serum biomarkers predict adjuvant chemotherapy-associated symptom clusters in radical resected colorectal cancer patients.

Li N, Lu J, Xia D, Jiang X, Wen X, Qin X, Chen Y, Wang T. Li N, et al. J Gastrointest Oncol. 2022 Feb;13(1):197-209. doi: 10.21037/jgo-21-904. J Gastrointest Oncol. 2022. PMID: 35284113 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,157 results

Search Page

Filters